HRAS Antikörper (AA 2-186)
Kurzübersicht für HRAS Antikörper (AA 2-186) (ABIN7178885)
Target
Alle HRAS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 2-186
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Rat GTPase HRas protein (2-186AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- HRAS (HRas proto-oncogene, GTPase (HRAS))
-
Andere Bezeichnung
- Hras
-
Hintergrund
-
Background: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
Aliases: Hras antibody, Hras1 antibody, GTPase HRas antibody, H-Ras-1 antibody, Transforming protein p21 antibody, c-H-ras antibody, p21ras) [Cleaved into: GTPase HRas antibody, N-terminally processed] antibody
-
UniProt
- P20171
-
Pathways
- p53 Signalweg, MAPK Signalweg, RTK Signalweg, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Hepatitis C, Autophagie, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling, BCR Signaling
Target
-